Kawasaki disease (KD) is an acute inflammatory process affecting the arterial wall that results in panvasculitis in infants and young children. A recent review of autopsies of KD patients, mostly accompanied with coronary artery abnormalities (CAAs), revealed that there were the threeassociated vasculopathic processes: acute necrotizing arteritis, subacute or chronic vasculitis, and luminal myofibroblastic proliferation (LMP) (1). Acute arteritis is predominantly characterized by neutrophilic infiltrate that can lead to necrosis in the vessel wall. Subacute vasculitis begins weeks after the onset of fever, can still be detected months to years later, and is closely associated with LMP. LMP is associated with the subacute process that occurs months to years after the disease onset and can result in luminal narrowing, which can lead to cardiac ischemia. These vascular remodeling processes have been provisionally designated as "KD vasculopathy". In this review, we focused on the latest updates on echocardiography and ultrasound for KD according to the processes of KD vasculopathy. Correspondence to: Nobutaka Noto, MD, PhD. Noto Children's Clinic, 4-12-6 Heiwadai, Nerima-ku, Tokyo 179-0083, Japan.Email: info@noto-clinic.com.Abstract: Kawasaki disease (KD) is a systemic vasculitis with a predilection for damage to the coronary arteries. In the acute phase, clinical decision making for KD relies on the measurements of the coronary z-score obtained by 2-dimensional echocardiography (2DE). In the convalescent phase, KD patients with coronary artery abnormalities (CAAs) eventually show arteriosclerotic vascular remodeling characterized by marked intimal proliferation and neoangiogenesis after KD vasculitis, which often induces myocardial ischemia. To date, several well-established surrogate markers including dobutamine stress echocardiography (DSE), the carotid intima-media thickness (CIMT) and flow-mediated dilatation (FMD), have been made available for risk assessment and the prediction of cardiovascular disease (CVD) in KD patients. Additionally, the use of carotid contrast-enhanced ultrasonography (CEUS), has enabled the visualization and quantification of the adventitial vasa vasorum (VV) network, assessing active vascular remodeling at remote arterial sites in KD patients with CAAs. However, there was no evidence of major vascular structural changes in KD patients in whom CAAs had never been detected. Thus, assessment of multiple modalities using 2DE may provide direct information not only on the vascular health but also on the stratification of the risk of CVD in KD patients with CAAs.